Top 14 Life Science companies in Stockholm, Stockholms Lan, Sweden
Meet the trailblazing entities significantly contributing to the growth and evolution of this sector.
Aurigon, established in 2000, is an independent, privately-owned contract research institute dedicated to preclinical services for human and veterinary pharmaceuticals, food and chemicals. Aurigon provides a full range of advisory and experimental services in pharmacology, bio-/analytics and toxicology. Ranging from early-phase product efficacy and safety evaluation to regulatory toxicology and late-stage pre-marketing testing, we cover all areas of non-clinical drug development. Aurigon is a trusted outsourcing partner for multinational pharmaceutical and chemical groups, food producers and dynamic biotechnology companies. With its international headquarters in Munich, Aurigon operates state-of-the-art GLP- and/or GMP-compliant facilities at its ATRC Aurigon Toxicological Research Center near Budapest.
HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders. Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specific therapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.
Science Services is a partner for systems, tools, aids, and materials for sample preparation in microscopy and ultracentrifugation. Their customers contact them through email, mobile, and online applications.
Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance, advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerland, GLSV acted as one team with a global perspective. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.
Kastanienbaum GmbH is a spin-off of the Institute of Robotics and Mechatronics of the German Aerospace Center (DLR-RMC). Kastanienbaum's vision is the coexistence of humans and robots. Therefore, Kastanienbaum develops innovative software solutions for safe physical human-robot interaction. With their worldwide unique concepts, solutions and algorithms for operating, programming, control and safety of robots it will finally become possible that humans and robots interact or even collaborate with each other.